Tuberculosis and HIV: latest news

Tuberculosis and HIV resources

Tuberculosis and HIV features

Tuberculosis and HIV in your own words

Tuberculosis and HIV news from aidsmap

More news

Tuberculosis and HIV news selected from other sources

  • We had to run our own trial for TB drugs – nobody else was doing it

    Four years ago, Médecins Sans Frontières (MSF) made the decision to sponsor and run its own tuberculosis clinical trial. The aim was to find a new treatment regimen for drug-resistant tuberculosis (TB) that was radically better than what was currently available. As an organisation that specialises in delivering short-term emergency healthcare, this was a bold and new direction to take. But it was a decision that came from our frustration, anger and impatience on behalf of the more than 20,000 people with TB that we treat every year. We felt compelled to search for improved treatments ourselves because too few pharmaceutical companies, organisations or universities were doing enough about it.

    02 June 2017 | The Guardian
  • South Africa: 'We Can't Accept the New HIV, TB Plan' - Treatment Action Campaign

    The new national strategic plan for HIV and TB is a plan that seems reasonable when considered in the abstract, but that risks falling apart when confronted by the realities of the public healthcare system and political context.

    04 April 2017 | AllAfrica
  • South Africa launches new plan to advance progress towards ending AIDS

    In the plan are a set of bold and ambitious targets which include reducing new HIV infections from 270 000 to less than 100 000 per year, reducing new tuberculosis (TB) infections from 450 000 to less than 315 000 per year and reaching the 90–90–90 targets.

    04 April 2017 | UNAIDS
  • Ensuring Migrants Have Access To HIV, TB Treatment Critical To Reversing Epidemics In Eastern Europe, Central Asia

    Michel Kazatchkine: There must be a halt to the deportation of migrants based on health status in the countries where it is still in practice; the region needs to ensure migrants have access to HIV services, including ART, and to full course TB/MDR-TB treatment in the host country; national and regional responses around infectious diseases like HIV and TB urgently need to be reviewed to include migrants as a vulnerable group.

    27 March 2017 | Kaiser Daily Global Health Policy Report / Huffington Post
  • UNAIDS warns that countries will miss the 2020 target of reducing HIV-associated TB deaths by 75% unless urgent action is taken

    On World Tuberculosis Day, 24 March, UNAIDS is urging countries to do much more to reduce the number of tuberculosis (TB) deaths among people living with HIV. TB is the most common cause of hospital admission and death among people living with HIV. In 2015, 1.1 million people died from an AIDS-related illness—around 400 000 of whom died from TB, including 40 000 children.

    27 March 2017 | UNAIDS press release
  • Health alert: India has 25% of the world's tuberculosis patients

    Rising rates of superbug tuberculosis (TB) are threatening to derail decades of progress against the contagious disease, experts said on Thursday, and new drugs powerful enough to treat them are few and far between.

    23 March 2017 | Hindustan Times
  • Tuberculosis deaths fall in Europe

    The number of people developing and dying from tuberculosis (TB) is falling in Europe, but among the most vulnerable - including migrants, prisoners and people who are HIV positive - there have been worrying increases, data showed on Monday.

    21 March 2017 | Reuters
  • TB/HIV co-infections up 40 percent across Europe over the last five years

    New data released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe ahead of World TB Day show that new tuberculosis (TB) cases and deaths in the 53 countries of the WHO European Region declined each year by 4.3% and 8.5% respectively between 2011 and 2015. However, new TB/HIV co-infections increased by 40% over the same time period.

    21 March 2017 | Eurekalert Inf Dis
  • ‘Significant success’ in reducing TB and HIV/Aids in SA’s prisons

    Data presented at a five-day stakeholder meeting shows ‘significant success in screening and treatment for tuberculosis in Free State, Northern Cape and KwaZulu-Natal prisons.

    16 March 2017 | Medical Brief
  • TB partners, patients ask: How does a bacterium responsible for nearly a third of drug-resistance deaths not make list of R&D priority pathogens?

    While the unveiling of a list highlighting the need to fund drug development against specific pathogens represented just a beginning for some antimicrobial resistance fighting efforts, the list represented a setback for TB drug development, advocates say.

    02 March 2017 | Science Speaks
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.